Skip to main content

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

David Tabernero Caellas

Institutions of which they are part

Senior researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Complejidad de la cuasiespecie del virus de la Hepatitis B en las regiones X, precore y core: Asociación con la severidad de la infección

IP: -
Collaborators: Clara Ramírez Serra, Lluis Castells Fusté, Silvia Camòs Anguila, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 98373
Reference: PI12/01893
Duration: 01/01/2013 - 31/03/2016

Prevalencia de las quasispecies mutantes en antígeno de superficie en paceintes con hepatitis crónica B y trasplantados por hepatitis B

IP: Maria Buti Ferret
Collaborators: Andrea Caballero Garralda, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 275715.44
Reference: PI11/01973
Duration: 01/01/2012 - 28/02/2015

Análisis de la cuasispecie viral en la infección por virus de la hepatitis B: evolución natural yu asociada al tratamiento antiviral

IP: -
Collaborators: Maria Buti Ferret, David Tabernero Caellas
Funding agency: Instituto de Salud Carlos III
Funding: 90750
Reference: PI09/00899
Duration: 01/01/2010 - 31/12/2012

Unitat de Recerca en Malalties Hepatobiliars

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Antonio González Fernández, Lluis Castells Fusté, Silvia Sauleda Oliveras, Lluís Palenzuela Díaz, Maria Buti Ferret, Josep Quer Sivila, Unitat de Recerca en Malalties Hepatobiliars, Juan Ignacio Esteban Mur, David Tabernero Caellas
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 54080
Reference: 2009 SGR 383
Duration: 01/01/2010 - 30/04/2014

Related news

This tool will help avoid invasive techniques and assist in selecting candidates for clinical trials of new treatments.

The meetings served to share advances in translational research and consolidate international scientific alliances in the study of liver diseases

The consensus establishes recommendations that could correct the current disparities related to muscle mass, weight and height and would allow for more precise prioritization of patients who require transplants more urgently.

Related professionals

Gemma Cuberas Borros

Gemma Cuberas Borros

Research technician
Molecular Imaging and Therapy
Read more
Rafael Simó Canonge

Rafael Simó Canonge

Head of group
Diabetes and Metabolism
Read more
Mar Xunclà  Lloret

Mar Xunclà Lloret

Predoctoral researcher
Genetics Medicine
Read more
Anna  Abuli  Vidal

Anna Abuli Vidal

Postdoctoral researcher
Genetics Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.